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Structural basis for recognition of the Sec4 Rab 
GTPase by its effector, the Lgl/tomosyn 
homologue, Sro7
ABSTRACT Members of the tomosyn/Lgl/Sro7 family play important roles in vesicle traffick-
ing and cell polarity in eukaryotic cells. The yeast homologue, Sro7, is believed to act as a 
downstream effector of the Sec4 Rab GTPase to promote soluble N-ethylmaleimide–sensitive 
factor adaptor protein receptor (SNARE) assembly during Golgi-to–cell surface vesicle trans-
port. Here we describe the identification of a Sec4 binding site on the surface of Sro7 that is 
contained within a cleft created by the junction of two adjacent β-propellers that form the 
core structure of Sro7. Computational docking experiments suggested four models for inter-
action of GTP-Sec4 with the Sro7 binding cleft. Further mutational and biochemical analyses 
confirmed that only one of the four docking arrangements is perfectly consistent with our 
genetic and biochemical interaction data. Close examination of this docking model suggests 
a structural basis for the high substrate and nucleotide selectivity in effector binding by Sro7. 
Finally, analysis of the surface variation within the homologous interaction site on tomosyn-1 
and Lgl-1 structural models suggests a possible conserved Rab GTPase effector function in 
tomosyn vertebrate homologues.
INTRODUCTION
Polarized exocytosis requires the proper localized delivery, dock-
ing, and fusion of secretory vesicles with sites of active growth on 
the plasma membrane. In the budding yeast Saccharomyces 
cerevisiae, secretory vesicles are delivered to specific plasma 
membrane sites where the Rab GTPase Sec4 mediates vesicle 
tethering through its interaction with the Exocyst complex sub-
unit Sec15 (Walch-Solimena et al., 1997; Guo et al., 1999). After 
vesicle tethering, a trans–soluble N-ethylmaleimide–sensitive fac-
tor adaptor protein receptor (SNARE) complex forms between 
the vesicle SNARE proteins Snc1/2 and the plasma membrane 
SNARE proteins Sec9 and Sso1/2, which drives vesicle fusion 
(Aalto et al., 1993; Protopopov et al., 1993; Brennwald et al., 
1994).
Genetic screens in yeast identified a Sec9-binding protein, Sro7, 
as an important regulator of Golgi-to–cell surface trafficking 
(Kagami et al., 1998; Lehman et al., 1999). Sro7 is a member of the 
structurally conserved Lethal giant larvae (Lgl)/tomosyn family of 
proteins involved in polarity. Lgl was first discovered in Drosophila 
melanogaster, in which mutant Lgl larvae suffer from imaginal disk 
outgrowth and show many of the properties of human tumor behav-
ior, such as loss of tissue architecture and cell shape and failure to 
differentiate (De Lorenzo et al., 1999). The exact mechanism of func-
tion for this family of proteins in cell polarity is controversial 
(Vasioukhin, 2006). Studies on Drosophila Lgl suggest that it func-
tions in regulating actin polarity by interacting with myosin II (Strand 
et al., 1994). Mammalian Lgl is also known to interact antagonisti-
cally with the Cdc42-Par6-atypical protein kinase C (aPKC) polarity 
complex to maintain the identity of the apical and basolateral mem-
branes in epithelial cells (Hutterer et al., 2004). The neuronal family 
member tomosyn-1 (or Stxbp5) forms a complex with syntaxin-1, 
SNAP25, and synaptotagmin, directly competing with VAMP (syn-
aptobrevin) for forming an active SNARE complex (Fujita et al., 
1998; Ashery et al., 2009). This suggests that tomosyn functions in 
polarity by regulating neurotransmitter release by affecting the 
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a GDP-dissociation inhibitor displacement factor facilitating the ac-
tivation of Rab10 instead of as a Rab GTPase effector transducing 
the GTP-Rab function.
This prompted us to further examine nucleotide and Rab-bind-
ing specificity of Sro7 with the yeast Rab GTPases. We therefore 
examined binding properties of Sro7 with representatives of each 
subgroup of the well-characterized yeast Rab GTPase family (Lazar 
et al., 1997; Buvelot Frei et al., 2006; Lipatova et al., 2015). Repre-
sentatives of each of the eight yeast Rab subfamilies—Sec4, Ypt1, 
Ypt32, Ypt51, Ypt6, Ypt7, Ypt10, and Ypt11—were purified from 
Escherichia coli as N-terminally tagged glutathione S-transferase 
(GST) fusions, immobilized on glutathione Sepharose beads, and 
exchanged with guanosine 5′-3-O-(thio)triphosphate (GTPγS), GDP, 
or no nucleotide (Figure 1). As seen in Figure 1, purified full-length 
Sro7 binds specifically to GTPγS-Sec4 and fails to show significant 
binding to any of the other seven Rab proteins tested (Figure 1). Of 
importance, Sro7 binding is completely dependent on Sec4 being 
in a GTP-bound, activated state, and no detectable binding was 
seen to GDP or nucleotide-free forms of any of the eight Rab 
GTPases in yeast. Taken together, these results indicate that the in-
teraction between Sro7 and the yeast Rabome is highly specific to 
Sec4 in its active or GTP-bound state.
Biochemical screen identifies two Sro7 mutants deficient 
in binding to Sec4-GTP
To begin to explore the molecular mechanism by which the Sec4 
GTPase regulates Sro7, we set out to identify the site(s) of interac-
tion between these proteins. The Sro7 is the only member of the 
Lgl/tomosyn protein family for which a high-resolution crystal struc-
ture has been determined (Hattendorf et al., 2007). Sequence analy-
sis based on close relatives of Sro7 combined with structural analysis 
identified a number of conserved surface patches as potential can-
didate sites on Sro7 for interaction with upstream regulators (i.e., 
the Rab Sec4) or downstream targets of its function (i.e., the target 
membrane SNARE [t-SNARE] Sec9). We focused our interrogation 
within each conserved patch on charged residues by creating 
formation of trans-SNARE complexes in exocytosis. In yeast, dele-
tion of Sro7 and its redundant homologue, Sro77, causes secretory 
vesicles to accumulate in the emerging bud, whereas the actin cyto-
skeleton is unperturbed (Lehman et al., 1999). This phenotype is 
similar to that of late secretory mutants and implicates that the Lgl/
tomosyn family functions in polarized exocytosis rather than cyto-
skeletal regulation.
Recent evidence suggests that Sro7 could also act as a direct 
effector of Sec4 (Grosshans et al., 2006). Sro7 was shown to bind to 
Sec4 in the presence of GTP and has genetic properties consistent 
with it functioning downstream of Sec4. However, there has not 
been rigorous testing that proves that the physical interaction with 
Sec4 is required for Sro7 function in vivo, so the mechanism of this 
interaction and whether it plays a role in exocytosis are unknown.
Sro7 is the only Lgl/tomosyn family member whose x-ray struc-
ture has been determined (Hattendorf et al., 2007). In this study, we 
used the crystal structure of Sro7 to identify charged surface patches 
on Sro7 and screened for their involvement in the Sro7–Sec4 inter-
action. We combined these in vitro results with in vivo suppression 
studies and in silico modeling to validate the Sro7–Sec4 docking 
interaction interface. We found that disruption of the Sro7–Sec4 in-
teraction results in a reduction of Sro7 function in vivo. Moreover, 
bioinformatic analysis suggests the possibility that the Sro7–Sec4 
Rab-binding interface may be conserved in vertebrate tomosyn-1.
RESULTS
The interaction between Sro7 and the yeast Rab GTPase 
Sec4 is specific and GTP dependent
We showed previously that Sro7 binds preferentially in vitro to the 
GTP-locked conformation of the yeast Rab GTPase Sec4 (Gross-
hans et al., 2006). More recently, Wang et al. (2011) reported an 
interaction between Lgl—the mammalian homologue of Sro7—
and the Rab10 GTPase, which may play a role during axonal mem-
brane protrusion. However, the biochemical analysis of this interac-
tion suggests that Lgl and Rab10 interact in a GDP- rather than 
GTP-dependent manner. This further suggests that Lgl1 may act as 
FIGURE 1: The interaction between Sro7 and the yeast Rab GTPase Sec4 is specific and GTP dependent. Soluble Sro7 
was tested for binding to eight representatives of the yeast Rab GTPase family immobilized on glutathione Sepharose 
beads after exchange with GTPγS, GDP, or no nucleotide. Coomassie gel compares the amounts of Rab GTPases used 
in the in vitro binding. Quantitation is based on three independent experiments.
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were purified to homogeneity from yeast using a previously de-
scribed multistep procedure (Rossi et al., 2015), and all proteins 
were subjected to SDS–PAGE and Coomassie staining to assess 
both purity and quantity of each preparation (Figure 2C).
As a first examination of overall protein integrity, we compared 
wild-type Sro7 and the Sro7 mutant proteins for binding to a known 
charge-reversal mutations because of their high likelihood to disrupt 
protein–protein interactions. We therefore generated a collection of 
12 different charge-reversal mutations that span both β-propeller 
domains of Sro7 and exclude known sites of interaction with the 
Sec9 N-terminus and with the regulatory tail of Sro7 (Figure 2, A and 
B; Hattendorf et al., 2007). Wild-type Sro7 and the Sro7 mutants 
FIGURE 2: Biochemical screen identifies two Sro7 mutants deficient in binding to Sec4-GTP. (A) Schematic of Sro7 
showing the N-terminal propeller in blue, the C-terminal propeller in green, and the autoinhibitory tail in light pink. Sites 
of charge-reversal mutations are indicated in fuchsia. (B) Surface-filling models of Sro7 showing the 12 residues 
subjected to mutation in fuchsia. (C) Coomassie gel of purified Sro7 and the Sro7 charge-reversal mutant proteins. 
Quantitation of Sro7 and Sro7 mutant protein binding to GST, GST-Sec9, or GST-Sec4 previously loaded with either 
GTPγS or GDP. Binding was expressed as a percentage, with wild-type Sro7 binding set to 100%. Quantitation in each 
graph was based on four independent experiments. (D) The mutant strain sec15-1 was transformed with a plasmid 
(CEN) expressing SRO7, the charge-reversal mutants, or vector only. Three independent transformants were picked into 
microtiter wells and transferred to YPD medium at 25 and 37°C. (E) Wild-type and SRO7 mutants unable to bind Sec4 
were integrated as the sole source at the SRO7 locus. Four independent colonies were picked into microtiter wells and 
transferred to YPD medium at 37, 25, and 17°C.
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of Sro7. Of interest, these sites suggest that both the N-terminal 
and C-terminal β-propeller domains contribute to Sec4 binding and 
implicate a cleft formed by the intersection of the two propeller 
domains of Sro7 (Figure 3B). The identification of these novel Sro7 
mutants piqued our interest in understanding the engagement be-
tween Sro7 and Sec4 in more detail. However, the relatively low af-
finity of the interaction between Sro7 and Sec4-GTP makes it unsuit-
able for analysis by cocrystallization experiments. Therefore we took 
an alternative approach that involved the combination of in silico 
docking studies with in vitro binding assays and in vivo suppression 
data to generate models for Sro7–Sec4 interaction. Like Sro7, the 
crystal structure of Sec4-GTP was previously determined (Stroupe 
and Brunger, 2000). We used the ClusPro 2.0 docking program to 
perform docking simulations between Sro7 and Sec4. The simula-
tions filtered conformations for low desolvation and electrostatic 
energies and ranked poses by cluster size for the best-scoring pro-
tein–protein complexes. The results revealed that four of the high-
scoring models include the involvement of Sro7 residues K395 and 
R599 or R600 in the in silico interaction with Sec4-GTP (shown in 
red, Figure 3B), which is consistent with the given in vitro binding 
data. In addition, all four models implicate one or both of the switch 
I and II regions of Sec4, which are the structural elements of Ras 
GTPases that change in response to the nucleotide state and are 
therefore strongly predicted to be involved in the interaction with an 
Sec4 effector protein such as Sro7.
All four Sro7–Sec4 docking models included the same Sro7 inter-
face for Sec4 binding (Figure 3A). This region is in a pocket on the 
opposing side of the protein from where the Sro7 regulatory tail and 
the t-SNARE Sec9 bind. To confirm that this Sro7 interface is in-
volved in binding to Sec4 as predicted by these four docking mod-
els and further delineate the site of Sec4 binding on Sro7, we cre-
ated a second set of Sro7 mutants at this interface (shown in orange, 
Figure 3B). We characterized the Sro7 mutants both in vitro by bind-
ing to Sec4-GTP and in vivo by analysis of their ability to suppress 
the growth defect of sec15-1 at 37°C. The results, shown in Figure 
3C, demonstrate that two of the three mutant proteins—Sro7-
D326R and Sro7-S327A, T329E—are deficient in binding to Sec4-
GTP, whereas Sro7-D361K binds Sec4-GTP comparably to wild-type 
Sro7. Similarly, when we examined the Sro7 mutants in vivo by test-
ing their ability to suppress the temperature sensitivity of sec15-1, 
we found that the same two mutants that are deficient in binding to 
Sec4-GTP—sro7-D326R and sro7-S327A, T329E—are also unable 
to suppress growth at the restrictive temperature (Figure 3C). Also 
consistent with the binding data, sro7-D361K suppresses sec15-1 at 
37°C similarly to wild-type SRO7 suppression (Figure 3C). As with 
our previous Sec4-binding mutants, these alleles show no obvious 
growth defects as the sole source in complementation of the severe 
cold-sensitive growth defect present in the sro7∆, sro77∆ double-
deletion strain (Supplemental Table I). The results of this character-
ization support the prediction that the Sro7 interface incorporated in 
the four docking models is highly likely to be a component of the 
binding site for Sec4-GTP. Moreover, these results are consistent 
with the previous finding in Figure 2 that Sro7 mutants unable to 
bind Sec4-GTP also demonstrate a clear defect in vivo to overcome 
the loss in Exocyst complex function present in sec15-1.
Novel mutations in Sec4 were designed to discriminate 
among predicted in silico docking models
Although the same binding interface of Sro7 is involved in all four 
docking models, the orientation of Sec4 with respect to Sro7 is sub-
stantially different in each model (Figure 4A). We therefore gener-
ated a second set of mutations in surface-exposed, charged Sec4 
Sro7 ligand, the t-SNARE Sec9 (Lehman et al., 1999). All 12 charge-
reversal mutants bind GST-Sec9 comparably to wild-type Sro7, and 
statistical analysis of the binding data demonstrates that differences 
are not significant (Figure 2C).
To determine whether any of the 12 surface patches on Sro7 
were involved in mediating specific binding to Sec4-GTP, we sub-
jected each of the purified mutant proteins to binding assays with 
Sec4 that had been exchanged with GTPγS or GDP. Of the 12 Sro7 
mutant proteins, two—Sro7-K395E and Sro7-R599E, R600E—no 
longer bind to Sec4-GTP, and the remaining 10 bind Sec4-GTP at 
levels statistically similar (p >0.05) to wild-type Sro7 (Figure 2C). 
None of the mutations has any detectable effect on the nucleotide 
specificity of the interaction with Sec4.
In parallel to the biochemical analysis of the surface patch mu-
tants, we examined the effect of each mutation on in vivo function, 
using two distinct genetic assays. First, we examined the ability of 
the Sro7 mutants to function as the sole source of Sro7 in the cell. 
A double deletion in Sro7 (sro7∆, sro77∆) and its redundant homo-
logue, Sro77, is cold sensitive and sensitive to salt, but one extra-
chromosomal copy of wild-type Sro7 complements this phenotype 
(Lehman et al., 1999; Wadskog et al., 2004). As the sole source of 
Sro7, all 12 of the charge-reversal mutants complement the cold 
and salt sensitivity of sro7∆, sro77∆ like wild-type SRO7 (Supple-
mental Table I). To determine whether the lack of any detectable 
growth phenotype for the two Sec4-binding deficient mutants was 
related to the presence of the mutants on an extrachromosomal 
plasmid, we integrated each defective allele (sro7-K395E and 
sro7-R600E), as well as an allele with both mutations (sro7-
K395E,R600E) into the native SRO7 locus by gene replacement 
(see Supplemental Figure S1 for details on the integration). The 
results of this analysis, shown in Figure 2E and Supplemental 
Figure S1, demonstrate that each of the single mutants is able to 
fully restore growth as the sole source of SRO7 at all temperatures 
and medium conditions examined, including 17oC and 0.7 M 
NaCl. Furthermore, the absence of a growth phenotype is unlikely 
due to residual binding present in each mutant, as the phenotype 
is identical to wild type even when both mutations are combined 
in a single allele (sro7-K395E,R600E).
The second genetic assay uses our previous observation that 
Sro7 plays a role as an effector of Sec4 that is parallel to the Exocyst 
complex, as overexpression of Sro7 strongly suppresses growth de-
fects associated with deletions or temperature-sensitive mutations 
in subunits of the Exocyst complex (Lehman et al., 1999; Zhang 
et al., 2005; Grosshans et al., 2006). Temperature-sensitive alleles of 
the Sec15 component of the Exocyst (sec15-1) are particularly sensi-
tive to small increases in SRO7 dosage, as just a single additional 
copy (CEN plasmid) is sufficient to suppress temperature sensitivity 
of sec15-1 at 37°C (Figure 2D). When the sec15-1 suppression anal-
ysis was extended to the collection of surface patch mutants, we 
found that only the sro7-K395E and sro7-R599E,R600E alleles dem-
onstrated loss of suppression. The other 10 surface patch alleles 
suppress sec15-1 temperature sensitivity at levels comparable to 
wild-type SRO7. Taken together with the binding data in Figure 2C, 
these results identify a potential surface(s) on Sro7 involved in the 
interaction with Sec4 both in vitro and in vivo.
Computational docking studies extracted interacting 
elements from the best-scoring complexes of Sro7 
and Sec4-GTP to produce four models
To examine the structural implications of the in vitro and in vivo ef-
fects of the described Rab binding mutants, we mapped the sites of 
the Sro7-K395 and Sro7-R599, R600 residues on the crystal structure 
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exhibit a significant defect in binding to Sro7, whereas two of the 
mutant Sec4 proteins bind to Sro7 at levels similar to that for wild-
type Sec4. To analyze the in vivo consequences of Sec4 mutations 
resulting in a loss of binding to Sro7, we used the fact that, like SRO7, 
one additional copy of SEC4 (on CEN) strongly suppresses the tem-
perature sensitivity of a sec15-1 strain (Salminen et al., 1987). As can 
be seen in Figure 4C, all four of the mutant alleles of SEC4 that en-
code proteins defective in binding to Sro7 in vitro also have com-
pletely lost the ability to suppress the sec15-1 mutant temperature 
sensitivity. Similarly, the two mutant SEC4 alleles that encode proteins 
that bind to Sro7 at levels similar to that of wild-type Sec4 also dem-
onstrate suppression of sec15-1 temperature sensitivity in a manner 
indistinguishable from that of wild-type SEC4. The strong correlation 
between the biochemical and genetic analyses strongly supports the 
notion that the interaction between Sec4 and Sro7 observed in vitro 
is also important for the function of both proteins within the cell.
residues with the aim of distinguishing among the four models. To 
accomplish this, we chose six residues to mutate with high predic-
tive value in distinguishing among the four models based on differ-
ences in their predicted distance from Sro7 in the four models. Resi-
dues were scored for high interaction potential when the distance 
was <4 Å and low interaction potential when the distance was >4 Å 
(Figure 5A). For example, the Sec4-D56R mutant is predicted to be 
involved in Sec4–Sro7 docking in models A, C, and D but not in 
model B. Therefore this particular mutation will discriminate model 
B from the other models. The locations of the novel set of Sec4 
mutations tabulated in Figure 5A are shown by a ribbon diagram in 
Figure 4B.
Wild-type Sec4 and the discriminatory Sec4 mutants were purified 
as GST fusion proteins, exchanged with either GTPγS or GDP, and 
tested for binding to wild-type Sro7. The binding data shown in 
Figure 4C demonstrate that four of the six mutant proteins tested 
FIGURE 3: Computational docking studies extracted interacting elements from the best-scoring complexes of Sro7 and 
Sec4-GTP to produce four models. (A) Surface-filling model of Sro7 with an overlay of the four Sec4 docking 
arrangements. The Sro7 N-terminal propeller is shown in blue, the C-terminal propeller is in green, and the C-terminal 
tail is in light pink. The Sec4 ribbon diagrams (models A–D) are colored in yellow, pink, red and purple, respectively. 
(B) Ribbon diagram of Sro7, with new mutations at the Sro7–Sec4 interface marked in orange. Original mutations are 
marked in red. (C) Purified wild-type Sro7 or Sro7 mutants were tested for binding to GST-Sec4 after exchange with 
either GTPγS or GDP. Western blot and quantitation from four independent experiments. The mutant strain sec15-1 was 
transformed with a plasmid (CEN) expressing SRO7, the novel discriminatory mutants, or vector only. Three 
independent transformants were picked into microtiter wells and transferred to YPD medium at 25 and 37°C.
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tions and the actual in vitro and in vivo data (Figure 5A). In addition, 
four of the five mutated Sec4 residues in model D are predicted to 
be within 4 Å of the Sro7–Sec4 binding interface and demonstrate a 
strong effect on both binding and suppression.
Three distinct patches of mutations on both proteins affecting 
the Sro7–Sec4 interaction correspond nicely between Sro7 (orange 
residues) and Sec4 (purple residues): Sro7-R599E, Sro7-R600E, and 
Sec4-D136R on the C-terminal β-propeller front side of the binding 
cleft (Figure 5, bottom inset), Sro7-K395E and Sec4-D56R on the 
N-terminal β-propeller front side of the binding cleft (Figure 5, bot-
tom inset), and Sro7-D326R, Sro7-T329K, Sec4-E80K, and Sec4-
R83D on the N-terminal β-propeller back side of the binding cleft 
(Figure 5, right inset). On the basis of this extensive analysis, we 
invalidated three of the four docking models and have substantial 
evidence that model D is the native docking arrangement for inter-
action between Sro7 and Sec4-GTP.
How does Sro7 selectively bind GTP-bound Sec4?
The results shown in Figure 1 demonstrate that Sro7 has the bio-
chemical properties of a Rab effector with high substrate specificity 
for Sec4, as we do not detect Sro7 interaction with any other Rab 
GTPase in yeast. In addition, the Sro7–Sec4 interaction is highly spe-
cific to the GTP-bound or activated form of Sec4. Our determination 
of a well-validated, high-resolution model for Sro7–Sec4 docking 
allows us to identify elements of the binding interaction that are 
likely responsible for these two effector-specificity aspects of Sro7 
with Sec4. Close examination of the model illustrates four regions 
within Sec4 that are in most intimate contact with Sro7 (Figure 6). 
Two of the regions in close contact with Sro7 are the switch I and 
We next examined whether the binding and suppression data 
would allow us to discriminate among the four docking arrange-
ments. We compiled the tabulated predicted effects of the Sec4 
mutations on Sro7–Sec4 binding for each of the four models based 
on the distance of the mutated residue from the Sro7 binding inter-
face (Figure 5A). As previously stated, low interaction potential 
(marked with a minus sign in Figure 5A) corresponds to mutated 
Sec4 residues at a distance >4 Å from Sro7, and high interaction 
potential (marked with a plus sign in Figure 5A) corresponds with 
mutated Sec4 residues at a distance of <4 Å from Sro7. Based on 
the in vitro and in vivo studies, mutations that blocked both Sro7 
binding and sec15-1 suppression are indicated with an asterisk, and 
those mutations that had no effect on binding and suppression are 
unmarked (Figure 5A). In interpreting these results, it is important to 
note that it is possible for a residue to be predicted within 4 Å of the 
interface and still not affect binding when mutated. However, when 
a mutated residue is >4 Å from the binding interface in a particular 
docking model, there is a strong prediction that the mutated resi-
due will have no effect on the observed in vitro interaction and in 
vivo suppression analyses. For example, in docking models A and B, 
Sec4-E80K is predicted to be >4 Å from the binding interface on 
Sro7, yet this mutant dramatically affected the Sro7–Sec4 interac-
tion both in vitro and in vivo. Therefore it is unlikely that models A 
and B are the correct docking arrangements between Sro7 and 
Sec4, and this is scored as an inconsistency (in red) in Figure 5A. As 
can be seen, models A–C all contain several inconsistencies with 
regard to comparison of predicted effects of mutations with effects 
observed in vitro and in vivo. In contrast, model D (Figure 5B) is the 
sole model with perfect correlation between its interaction predic-
FIGURE 4: Novel mutations in Sec4 were designed to discriminate between predicted in silico docking models. (A) In 
the surface-filling models (A–D) of Sro7, the N-terminal propeller is shown in blue, the C-terminal propeller in green, and 
the C-terminal tail in light pink. The Sro7 mutations defective in binding Sec4-GTP (cyan) are shown in red. (B) Ribbon 
diagram of Sec4-GTP, with discriminatory mutations in purple. (C) Wild-type Sec4 or Sec4 mutants were purified as GST 
fusion proteins and bound to Sro7 as previously described. Western blot of binding and quantitation from four 
independent experiments. Sec15-1 was transformed with a plasmid (CEN) expressing SEC4, the discriminatory mutants, 
or vector only. Three independent transformants were picked into microtiter wells and transferred to YPD medium at 
25 and 37°C.
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We found that the Sro7-interacting region 
within the Sec4 switch II domain is highly 
conserved within the yeast Rabome (Figure 
6). Therefore the interaction of Sro7 with the 
switch II domain of Sec4 is unlikely to be in-
volved in mediating Rab specificity but 
instead likely plays a role in determining 
the nucleotide-binding-state specificity of 
the protein. Like the switch II domain, the 
C-terminal half of the Sec4 switch I domain 
(residues 52–58) is also highly conserved 
among the yeast Rab GTPases (Figure 6). In 
contrast, the first six residues of the switch I 
domain (residues 46–51) of Sec4 are quite 
distinct from those of the homologous 
switch I domains in the other yeast Rabs 
(Figure 6, dark blue residues boxed in yel-
low). In fact, of the four contact sites in our 
model used by Sro7 to bind Sec4, only this 
segment of the Sec4 switch I domain dem-
onstrates the kind of variability that one 
would expect of a site responsible for the 
Sro7 substrate specificity. Taking the results 
together, we conclude that whereas Sro7 
contact with both the switch I and switch II 
domains is likely responsible for recognition 
of the GTP-bound state of Sec4, it is the 
specific interaction with the N-terminal seg-
ment of the switch I domain that provides 
the high degree of Rab specificity for recog-
nition of Sec4-GTP by the Sro7 effector 
protein.
Conservation of the Sro7–Sec4 
binding interface within the Lgl 
family of proteins
Structural and evolutionary examination of 
surface residue variation has demonstrated 
that protein–protein interfaces are signifi-
cantly more constrained in their variability 
than are noninteraction surfaces (Levin 
et al., 2009; Dey et al., 2010). Structural 
alignments of Sro7 with its closest verte-
brate homologues, tomosyn and Lgl, dem-
onstrate that the overall dual–β-propeller 
domain structure of Sro7 is likely shared by 
all three members of this family (Hattendorf 
et al., 2007). Because the SNARE regulatory 
function is shared between yeast and vertebrate homologues 
(Sakisaka et al., 2004), it is possible that the Rab effector function is 
also shared with one or more of the vertebrate homologues. If so, 
one might expect to see reduced surface variability within the re-
gion predicted to form the homologous Sro7–Sec4 binding cleft. 
We therefore used a combined structural and phylogenetic ap-
proach to examine the surface variability of vertebrate members of 
tomosyn and Lgl, especially within the region homologous to where 
Sec4 interacts with Sro7. We used the MODELLER program to build 
structural models of tomosyn-1 and Lgl-1, using the crystal struc-
ture of Sro7 as a template. The tomosyn-1 model is similar to that 
made by Williams et al. (2011). We then mapped onto the models 
invariant residues identified from multiple sequence alignments. 
A multiple sequence alignment of 16 Sro7 homologues from the 
switch II domains of Sec4—the two regions that undergo the most 
conformational change when comparing GDP and GTP-bound 
structures, which are therefore critical to nucleotide-specific recog-
nition of small GTPases by effectors and accessory proteins (Vetter 
and Wittinghoffer, 2001). The four Sro7 contact regions within Sec4 
are residues 46–58 (the entire switch I domain), residues 79–84 
(within the switch II domain), Sec4-135-140, and Sec4-162-167. The 
first two regions make contact with the Sro7 N-terminal β-propeller 
domain; the latter two interact with the Sro7 C-terminal β-propeller 
domain.
To determine which of these four regions is likely used by Sro7 to 
distinguish Sec4 from other Rab GTPases in yeast, we examined 
sequence alignments of the eight yeast Rab family members used in 
Figure 1—Sec4, Ypt1, Ypt31, Vps21, Ypt10, Ypt6, Ypt7, and Ypt11. 
FIGURE 5: Mutations in Sec4 predict a precise model for the docking of Sec4 onto the binding 
cleft of Sro7. (A) Table of interaction predictions for Sec4 discriminatory mutations specific to 
each docking model based on their distance from Sro7. Distances >4 Å were scored as a low 
interaction prediction (–), and distances <4 Å were scored as a high interaction prediction (+). 
Based on in vitro and in vivo characterization, mutations that affected the interaction are 
indicated with an asterisk. Results inconsistent with the initial interaction prediction are indicated 
in red. (B) Validated docking interaction between Sro7 and Sec4-GTP. Sro7 residues involved in 
the interaction are shown in orange. Sec4 residues involved in the interaction are shown in 
purple. Insets are enlargements of docking site straight on (bottom inset) and at a 90° rotation 
(right inset).
3296 | K. Watson et al. Molecular Biology of the Cell
served sites in the Sro7–Sec4 binding pocket—one on the C-termi-
nal β-propeller including the Sro7-R600 residue and one on the 
N-terminal β-propeller including the Sro7-K395 residue (Sro7 inset, 
Figure 7). Residues Sro7-R600 and Sro7-K395 were previously 
shown to be directly involved in the Sro7–Sec4 interaction (Figure 2). 
The conserved Sro7-K395 area in the docked Sro7–Sec4 structure 
interacts with the Sec4 switch I domain (yellow), the region of Sec4 
responsible for effector specificity, consistent with the correlation 
between decreased protein surface variability and functional impor-
tance (Sro7 inset, Figure 7).
Human tomosyn-1 and Lgl-1 protein sequences were used to 
build structural models based on the Sro7 crystal structure tem-
plate. As with the yeast family members, invariant surface resi-
dues within tomosyn and Lgl vertebrate homologues were 
mapped onto the structural models of tomosyn-1 and Lgl-1. In 
contrast to yeast, tomosyn family members have several con-
served regions spanning both faces of its dual-propeller struc-
ture, likely attributed to increased surface fixation from acquired 
functionality (Figure 7). Like tomosyn, Lgl vertebrates also 
Saccharomycetaceae family, one family of budding yeast, was used 
for comparison (Figure 7, left). Invariant residues were also identi-
fied from an alignment of 47 tomosyn-1 vertebrate (fish, frog, bird, 
and mammal) homologues (Figure 7, middle) and from 34 Lgl-1 
vertebrate homologues (Figure 7, right). Conserved invariant resi-
dues are indicated in pink on the Sro7 crystal structure and the to-
mosyn and Lgl structural models, respectively (Figure 7). Although 
rates of surface change are overall much greater in the yeasts com-
pared with vertebrates (presumably due to both functional redun-
dancy with the Exocyst complex and much shorter generation 
time), specific sites of low variability are apparent in all three family 
members.
There are three areas on the surface of Sro7 with decreased vari-
ability within the yeast family: regions homologous to where the 
Sro7 regulatory tail binds back to the N-terminal β-propeller, the 
binding site for the N-terminus of the t-SNARE Sec9 (Hattendorf 
et al., 2007), and residues within the Sro7–Sec4 binding pocket 
(Figure 7). When we focus specifically on the Sec4 binding cleft on 
Sro7, the variability among the yeast members reveals two con-
FIGURE 6: Sec4 effector specificity for Sro7 interaction is attributed to the Sec4 N-terminal half of the switch I domain. 
(A) Crystal structure of Sro7 docked with Sec4-GTP (gray). The N-terminal propeller is blue, the C-terminal propeller is 
green, and the autoinhibitory tail is light pink. Ribbon diagram of Sec4 is shown with the switch I domain in yellow 
(residues 48–56) and the switch II domain in cyan (residues 76–93). Sro7 residues involved in the interaction are shown in 
orange. (B) Multiple sequence alignments were performed using ClustalX with each of the eight yeast Rab family 
member representative proteins (Ypt1, Ypt31, Vps21, Ypt10, Ypt6, Ypt7, and Ypt11). The Sec4 switch I sequence is 
boxed in yellow, and the Sec4 switch II sequence is boxed in cyan. Switch domain residues within 4 Å of Sro7 are 
highlighted as either highly variable (dark blue) or highly conserved (light red) for the eight yeast Rab proteins.
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brate tomosyn-1 family members maintain significant conserva-
tion within the interaction interface. Of note, there is a cluster of 
invariant residues in tomosyn-1 that corresponds to the part of 
the binding cleft in Sro7 containing the critical K395 residue 
(tomosyn inset, Figure 7).
developed greater surface residue conservation; however, the 
invariant residues are located primarily on one protein face—
the same face where the aPKC phosphorylation sites reside 
(Figure 7). A focused examination of the region of tomosyn that is 
homologous to the Sro7–Sec4 binding pocket reveals that verte-
FIGURE 7: Conservation of the Sro7–Sec4 binding interface within the Lgl family of proteins. Crystal structure of Sro7 
(left) and structural models of tomosyn-1 (middle) and Lgl-1 (right) docked with Sec4-GTP (gray). Structural models were 
built with MODELLER, using the crystal structure of Sro7 as a template. The tomosyn-1 model is similar to that shown 
by Williams et al. (2011), except that unstructured insertions are omitted from the structural models shown. The 
N-terminal propeller is blue, the C-terminal propeller is green, and the regulatory tail is light pink. Ribbon diagrams of 
Sec4 are shown with the switch I domain in yellow and the switch II domain in cyan. Invariant residues were identified 
from three multiple sequence alignments. One alignment was of 16 Sro7 homologues from the Saccharomycetaceae 
family of budding yeast, a second of 47 tomosyn-1 vertebrate homologues, and a third of 34 Lgl-1 vertebrate 
homologues. Sites of invariant conserved residues are indicated in pink on corresponding structures. Structures flipped 
vertically 180° were also slightly rotated horizontally 30° to better view the binding pocket. Insets are enlargements of 
homologous Sro7–Sec4 binding site straight on. The Sro7 C-terminal tail and Sec9 N-terminus binding sites are 
indicated in the Sro7 crystal structure (top left). Conserved Sro7 residues involved in the Sro7–Sec4 interaction are 
indicated in the Sro7 inset (left inset). Invariant tomosyn-1 residues that correspond with the Sro7-K395 site are 
indicated in the tomosyn-1 model (middle inset). The aPKC-phosphorylated residues on Lgl are within one of the 
omitted unstructured insertions. This region is indicated in the Lgl-1 structural model (middle right).
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and which aspects are unique to Sro7 or the Exocyst in carrying out 




Yeast growth media used in this study include 1% bacto-yeast 
extract, 2% bacto-peptone, 2% dextrose (YPD; Difco, Sparks, MD), 
S minimal (0.67% yeast nitrogen base without amino acids and 2% 
dextrose; Difco), agar (Fisher Scientific, Pittsburgh, PA), and dropout 
media (0.67% yeast nitrogen base without amino acids, synthetic 
complete amino acid supplement minus appropriate amino acid(s), 
and 2% dextrose; US Biological, Swampscott, MA).
Bacteria growth media used in this study include Terrific Broth 
(4.7% bacto-TB, 1% glycerol; Fisher Scientific), Super Optimal Broth 
(SOB; 2% tryptone; Difco), 0.5% bacto-yeast extract, 2.5 mM KCl 
(Sigma-Aldrich, St. Louis, MO), 1 M NaCl, 10 mM MgCl2, and 
10 mM MgSO4 (Fisher Scientific), SOB with catabolite repression 
(SOB + 2.5% glucose), and lysogeny broth (1% bacto-tryptone, 
0.5% bacto-yeast extract, and 1% NaCl).
Reagents used in this study were as follows: GTPγS, Triton 
X-100, GDP, sodium azide, sodium fluoride, dithiothreitol (DTT), 
β-mercaptoethanol, pepstatin A, and leupeptin 1 mg/ml, aprotinin 
2 mg/ml, and antipain 1 mg/ml were obtained from Sigma-Aldrich. 
Ampicillin and 4-(2-aminoethyl) benzenesulfonyl fluoride were 
obtained from US Biological. Tween-20 and Broad Range Protein 
Standard were obtained from Bio-Rad (Hercules, CA). Glutathione 
Sepharose 4B, Protein A Sepharose, and Precision Protease were 
obtained from GE Healthcare (Milwaukee, WI). Secondary antibod-
ies for the Odyssey Imaging System are from LI-COR Biosciences 
(Lincoln, NE) and Molecular Probes (Eugene, OR). 5-Fluoroorotic 
acid was obtained from Thermo Scientific (Waltham, MA). Immuno-
globulin G Sepharose 6 Fast Flow beads were obtained from 
Amersham Biosciences (Piscataway, NJ).
Yeast strains and genetic analysis
The yeast strains that were constructed and used for this study are 
listed in Supplemental Table II. Yeast transformations were per-
formed using the lithium acetate method (Moerschell et al., 1991). 
For genetic analysis, at least three different spores were analyzed 
per experiment.
Plasmids and molecular biology
The plasmids that were constructed and used for this study are 
listed in Supplemental Table III. Sro7 charge-reversal mutants were 
generated by site-directed mutagenesis on pB2129 (Sro7, CEN, 
HIS3 plasmid). Protein A–tagged Sro7 constructs were generated as 
BamHI/HindIII subclones in pB966 (Protein A, 2 μ plasmid) as previ-
ously described (Rossi et al., 2015). Sro7 charge-reversal mutants 
were generated by site-directed mutagenesis on pB1931 (Sec4, 
CEN, LEU2 plasmid). GST-tagged Sec4 constructs were generated 
as BamHI-SalI fragments in pB 2173 (pGEX-6P1 plasmid). GST-
tagged Rab protein constructs were generated using genomic DNA 
as BamHI-SalI fragments (Ypt32, Ypt51, Ypt1, Ypt6, Ypt7, Ypt10) or 
BglII-SalI (Ypt11) fragments and subcloned into pB 2173 (pGEX-6P1 
plasmid). Constructs were confirmed by sequencing.
Protein purification
Wild-type Sro7 and Sro7 charge-reversal mutant proteins were puri-
fied as previously described (Rossi et al., 2015). GST fusion proteins 
(Sec4, Sec4 charge-reversal mutants, Ypt32, Ypt51, Ypt1, Ypt6, Ypt7, 
Ypt10, and Ypt11) were transformed into BL21 E. coli and expressed 
Of interest, the surface conservation in vertebrate Lgl-1 mem-
bers is quite distinct from the conservation observed in vertebrate 
tomosyn-1 proteins. Whereas there is a significant increase in overall 
Lgl surface residue conservation compared with Sro7 and tomo-
syn-1, the region corresponding to the Sec4 binding pocket in Sro7 
is significantly more variable in Lgl-1 (Lgl inset, Figure 7). This sug-
gests that of the two vertebrate branches of the Sro7/Lgl/tomosyn 
family, tomosyn is the most likely to have a conserved role as an 
effector for a vertebrate Rab GTPase.
DISCUSSION
This study describes for the first time the structural details of the 
Sec4 GTPase interaction with a direct downstream effector, Sro7. 
Whereas previous work detailed the interaction between Sro7 and 
its downstream t-SNARE target, Sec9, this study gives the first struc-
tural clues as to how a member of the Lgl/tomosyn/Sro7 family of 
proteins is engaged by a Rab GTPase. One of the defining charac-
teristics of the Lgl/tomosyn/Sro7 family is the central structure com-
posed of two adjacent seven-bladed β-propellers having extensive 
interactions between the N- and C-terminal propellers (Hattendorf 
et al., 2007). Here we map the binding site used by the Sec4 GTPase 
in its interaction with Sro7 to a cleft formed at the intersection of 
these two propellers—an interaction that is highly specific to the 
yeast Rab family member Sec4 in its activated, GTP-bound form.
Our bioinformatic analysis of the sequence variation found in 
vertebrate members of the tomosyn1/2 family suggests that this 
cleft may also be important for the interaction between tomosyn 
and a related small GTPase, perhaps as part of an ancestral function 
for this family of proteins that predates the divergence of the family 
members (Fasshauer and Jahn, 2007; Kloepper et al., 2008). Of in-
terest, there is significantly less conservation in the homologous 
Sro7–Sec4 binding interface for members of the Lgl1/2 family than 
for tomosyn1/2. We can only speculate about the precise signifi-
cance of this difference, but it could be attributed to divergence or 
loss of the ancestral Rab effector function as the Lgl family evolved 
distinct functions from tomosyn in metazoans. This functional sepa-
ration between family members could have occurred in parallel to 
the loss of the C-terminal R-SNARE motif in members of the Lgl 
family in metazoans (Fasshauer and Jahn, 2007). Of interest, Wang 
et al. (2011) reported a direct interaction between Lgl1 and the 
Rab10 GTPase. However, unlike the GTP-dependent Sro7–Sec4 in-
teraction, Lgl1 appears to interact specifically with the GDP- rather 
than GTP-bound form of Rab10.
A surprising aspect of this study arose when we were investigat-
ing the importance of interaction with the Sec4 GTPase to the in 
vivo function of Sro7 within the cell. Although there is an absolute 
requirement for Sro7–Sec4 interaction to rescue the late secretory 
mutant sec15-1, mutant forms of Sro7 that are unable to bind Sec4-
GTP, show no detectable growth or secretion defect when present 
as the sole source of sro7 and sro77 in the cell (Supplemental Table 
I). The simplest explanation for this behavior is that Sro7 function 
overlaps significantly with the function of the Exocyst complex as 
part of a dual or parallel effector pathway. The Exocyst and Sro7 
were both shown to bind directly to Sec4-GTP and have SNARE 
regulatory properties (Grosshans et al., 2006; Hattendorf et al., 
2007; Heider et al., 2012). In fact, overexpression of Sro7 suppresses 
a number of mutations and deletions in components of the Exocyst 
and has genetic properties consistent with a parallel function 
(Lehman et al., 1999; Grosshans et al., 2006). Further work will allow 
us to determine more precisely which aspects of the Sec4/Sro7 ef-
fector pathway (vesicle tethering vs. SNARE assembly) represent 
elements functioning in parallel to those of the Exocyst complex 
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as previously described (Grosshans et al., 2006). Sec9 with a 
C-terminal hexahistidine tag was purified from E. coli as previously 
described (Gangar et al., 2005).
In vitro binding assays
In vitro binding of wild-type Sro7 and Sro7 charge-reversal mutants 
to GST fusions of Sec9, Sec4, Sec4 mutants, and the seven Rab fam-
ily proteins was performed using previously described conditions 
(Grosshans et al., 2006) with the following modifications. During 
nucleotide exchange, beads were incubated with 100 μM GTPγS or 
GDP or nucleotide free for 30 min at 25°C. After this incubation, 
MgCl2 was added to a final concentration of 30 mM and incubated 
for 1 h at 25°C. Binding buffer consisted of 20 mM Tris-HCl, pH 7.4, 
140 mM NaCl, 10 mM McCl2, 1 mM DTT, and 0.5% Triton X-100. In 
vitro binding of wild-type Sro7 and Sro7 charge-reversal mutants to 
GST-Sec9 (full length) was performed using previously described 
conditions (Gangar et al., 2005). Binding percentages for all in vitro 
binding experiments were expressed as percentage of binding rela-
tive to wild-type Sro7 binding. The p values were determined using 
Student’s t test from three separate binding experiments for each 
protein.
Protein–protein docking analysis
Docking simulations between Sro7 and Sec4 were performed with 
the automated docking server ClusPro 2.0 (Comeau et al., 2004), 
using solved crystal structures for Sro7 (Hattendorf et al., 2007; 
Protein Data Bank [PDB] Code 2OAJ) and for GTP-Sec4 (Stroupe 
and Brunger, 2000; PDB Code 1G17). We did not use the ad-
vanced option of attractive residues to drive the complex toward 
the regions of interest on Sro7 and Sec4 during the ClusPro dock-
ing calculations. ClusPro results were refined complex structures 
based on the largest clusters of poses that represent the most 
likely protein–protein interactions. We analyzed the top 10 clusters 
for each of four scoring functions provided: 1) Balanced, 2) Electro-
static-favored, 3) Hydrophobic-favored, and 4) VdW+Electrostatic. 
The 40 ClusPro complexes were analyzed for docking poses that 
placed D56 of switch I and/or E80 of switch II of GTP-Sec4 near 
Sro7 residues R599/R600 and/or K395. From the 40 docking 
poses, the top 10 poses for each of the four scoring functions in-
cluded nine poses that involved both the Sec4 and Sro7 residues 
of interest. These nine poses could be separated into four unique 
poses, as some poses were identified as large clusters for more 
than one scoring function. A contact analysis for residues in Sec4 
within 4 Å of Sro7 interface residues was calculated using PyMOL 
tools (Jones et al., 2012).
Tomosyn-1 and Lgl-1 model building
The sequences for human tomosyn-1 and Lgl-1 were submitted to 
the HHpred fold recognition server (toolkit.tuebingen.mpg.de/
hhpred). The 14 WD-repeat structure of yeast Sro7 was identified as 
a top hit. The models of tomosyn-1 and Lgl-1 were built using 
MODELLER (Eswar et al., 2006) based on the yeast Sro7 (PDB ID 
2OAJ) template.
Sequence analysis
Sequences for vertebrate tomosyn-1 and for tomosyn homologues 
in the hemichordate acorn worm (Saccoglossus kowalevskii) and the 
echinoderm purple sea urchin (Strongylocentrotus purpuratus) were 
identified using BLAST (Altschul et al., 1990) and aligned in ClustalX 
(Higgins and Sharp, 1988; Thompson et al., 1997). A similar proce-
dure was followed for Lgl-1 homologues in vertebrates and the 
higher metazoans.
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